SAB BIOTHERAPEUTICS INC (SABS) Stock Balance Sheet
USA - NASDAQ:SABS - US78397T2024 - Common Stock
3 USD
-0.03 (-0.99%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 3.69M | 8.90M | 56.57M | 15.05M | 33.21M | |||
| Marketable Securities | 2.02M | 11.86M | N/A | N/A | N/A | |||
| Receivables | 0.00 | 55.00K | 0.00 | 5.56M | 8.01M | |||
| Other Current Assets | 3.59M | 2.98M | 2.34M | 1.49M | 8.97M | |||
| Total Current Assets | 9.31M | 23.79M | 58.91M | 22.10M | 50.19M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.40M | 19.92M | 24.68M | 28.34M | 30.95M | |||
| Other Non-Current Assets | 417.50K | 482.10K | 350.00K | 468.00K | 0.00 | |||
| Total Non-Current Assets | 20.82M | 20.40M | 25.03M | 28.81M | 30.95M | |||
| TOTAL ASSETS | 30.13M | 44.20M | 83.94M | 50.91M | 81.14M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 148.20K | 418.40K | 1.18M | 905.00K | 1.96M | |||
| Accrued Expenses | 7.91M | 5.87M | 7.32M | 10.36M | 13.38M | |||
| Accounts Payable | 2.62M | 1.69M | 946.00K | 3.68M | 4.46M | |||
| Other Current Liabilities | N/A | 0.00 | 1.36M | 50.00K | 6.66M | |||
| Total Current Liabilities | 10.68M | 7.98M | 10.81M | 14.99M | 26.45M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.20M | 3.28M | 3.42M | 4.17M | 3.76M | |||
| Other Non-Current Liabilities | 4.24M | 6.97M | 12.41M | 682.00K | 12.37M | |||
| Total Non-Current Liabilities | 7.44M | 10.25M | 15.83M | 4.85M | 16.14M | |||
| TOTAL LIABILITIES | 18.11M | 18.23M | 26.64M | 19.85M | 42.59M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -139.48M | -124.17M | -90.06M | -47.87M | -29.13M | |||
| Additional Paid In Capital | 157.03M | 155.79M | 152.86M | 84.44M | 67.67M | |||
| Common Shares | 1.00K | 1.00K | 1.00K | 5.00K | 4.00K | |||
| Treasury Stock | -5.52M | -5.52M | -5.52M | -5.52M | 0.00 | |||
| Other Shareholders' Equity | -15.80K | -135.40K | 26.00K | N/A | N/A | |||
| Shares Outstanding | 9.29M | 9.29M | 9.22M | 5.04M | 4.35M | |||
| Tangible Book Value per Share | 1.29 | 2.80 | 6.21 | 6.16 | 8.86 | |||
| Total Shareholders' Equity | 12.02M | 25.97M | 57.30M | 31.06M | 38.55M | |||
| TOTAL LIABILITIES AND EQUITY | 30.13M | 44.20M | 83.94M | 50.91M | 81.14M | |||
| Statistics | ||||||||
| Debt/Equity | 0.27 | 0.13 | 0.06 | 0.13 | 0.10 | |||
| Current Ratio | 0.87 | 2.98 | 5.45 | 1.47 | 1.90 | |||
| Return On Assets (ROA) | -122.99% | -77.17% | -50.27% | -36.82% | -21.13% | |||
| Return On Equity (ROE) | -308.38% | -131.33% | -73.64% | -60.34% | -44.47% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21